US Patent No. 9,133, 461

Compositions and methods for inhibiting expression of the ALAS1 gene
Sep 17, 2015

Alnylam Pharmaceuticals and Icahn School of Medicine at Mount Sinaihave been awarded US Patent No. 9,133,461, "Compositions and methods for inhibiting expression of the ALAS1 gene." 

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.